Inspire Medical Systems, Inc. Earnings Per Share (Basic)
Inspire Medical Systems, Inc. (INSP) reported Earnings Per Share (Basic) of $0.01 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-03
- Inspire Medical Systems, Inc. earnings per share, basic for the quarter ending 2026-06-30 was $0.01.
- Inspire Medical Systems, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.39, a 490.00% decline year-over-year.
- Inspire Medical Systems, Inc. earnings per share, basic for the quarter ending 2025-12-31 was $4.70, a 298.24% increase year-over-year.
- Inspire Medical Systems, Inc. earnings per share, basic for the quarter ending 2025-09-30 was $0.34, a 45.16% decline year-over-year.
- Inspire Medical Systems, Inc. earnings per share, basic for fiscal 2025 was $4.95, a 175.00% increase from fiscal 2024.
- Inspire Medical Systems, Inc. earnings per share, basic for fiscal 2024 was $1.80.
- Inspire Medical Systems, Inc. earnings per share, basic for fiscal 2023 was -$0.72.
- Inspire Medical Systems, Inc. earnings per share, basic for fiscal 2022 was -$1.60.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.01 10-Q · filed 2026-08-03 | -$0.38 10-Q · filed 2026-08-03 | $4.34 derived: net income ÷ weighted average shares · filed 2026-08-03 | $4.66 derived: net income ÷ weighted average shares · filed 2026-08-03 |
| 2026-03-31 | -$0.39 10-Q · filed 2026-05-04 | $4.33 derived: net income ÷ weighted average shares · filed 2026-08-03 | $4.65 derived: net income ÷ weighted average shares · filed 2026-08-03 | $4.50 derived: net income ÷ weighted average shares · filed 2026-08-03 |
| 2025-12-31 | $4.70 derived: net income ÷ weighted average shares · filed 2026-02-13 | $5.01 derived: net income ÷ weighted average shares · filed 2026-02-13 | $4.87 derived: net income ÷ weighted average shares · filed 2026-08-03 | $4.95 10-K · filed 2026-02-13 |
| 2025-09-30 | $0.34 10-Q · filed 2025-11-03 | $0.22 derived: net income ÷ weighted average shares · filed 2026-08-03 | $0.32 10-Q · filed 2025-11-03 | $1.51 derived: net income ÷ weighted average shares · filed 2026-08-03 |
| 2025-06-30 | -$0.12 10-Q · filed 2026-08-03 | -$0.02 10-Q · filed 2026-08-03 | $1.17 derived: net income ÷ weighted average shares · filed 2026-08-03 | $1.79 derived: net income ÷ weighted average shares · filed 2026-08-03 |
| 2025-03-31 | $0.10 10-Q · filed 2026-05-04 | $1.28 derived: net income ÷ weighted average shares · filed 2026-08-03 | $1.90 derived: net income ÷ weighted average shares · filed 2026-08-03 | $2.23 derived: net income ÷ weighted average shares · filed 2026-08-03 |
| 2024-12-31 | $1.18 derived: net income ÷ weighted average shares · filed 2026-02-13 | $1.80 derived: net income ÷ weighted average shares · filed 2026-02-13 | $2.13 derived: net income ÷ weighted average shares · filed 2026-02-13 | $1.80 10-K · filed 2026-02-13 |
| 2024-09-30 | $0.62 10-Q · filed 2025-11-03 | $0.95 derived: net income ÷ weighted average shares · filed 2025-11-03 | $0.61 10-Q · filed 2025-11-03 | $1.11 derived: net income ÷ weighted average shares · filed 2026-02-13 |
| 2024-06-30 | $0.33 10-Q · filed 2025-08-04 | -$0.01 10-Q · filed 2025-08-04 | $0.49 derived: net income ÷ weighted average shares · filed 2026-02-13 | $0.20 derived: net income ÷ weighted average shares · filed 2026-02-13 |
| 2024-03-31 | -$0.34 10-Q · filed 2025-05-05 | $0.16 derived: net income ÷ weighted average shares · filed 2026-02-13 | -$0.13 derived: net income ÷ weighted average shares · filed 2026-02-13 | -$0.53 derived: net income ÷ weighted average shares · filed 2026-02-13 |
| 2023-12-31 | $0.50 derived: net income ÷ weighted average shares · filed 2026-02-13 | $0.21 derived: net income ÷ weighted average shares · filed 2026-02-13 | -$0.20 derived: net income ÷ weighted average shares · filed 2026-02-13 | -$0.72 10-K · filed 2026-02-13 |
| 2023-09-30 | -$0.29 10-Q · filed 2024-11-04 | -$0.70 derived: net income ÷ weighted average shares · filed 2024-11-04 | -$1.23 10-Q · filed 2024-11-04 | |
| 2023-06-30 | -$0.41 10-Q · filed 2024-08-06 | -$0.94 10-Q · filed 2024-08-06 | ||
| 2023-03-31 | -$0.53 10-Q · filed 2024-05-07 | |||
| 2022-12-31 | -$1.60 10-K · filed 2025-02-10 | |||
| 2022-09-30 | -$0.60 10-Q · filed 2023-11-07 | -$1.12 derived: net income ÷ weighted average shares · filed 2023-11-07 | -$1.73 10-Q · filed 2023-11-07 | |
| 2022-06-30 | -$0.53 10-Q · filed 2023-08-01 | -$1.13 10-Q · filed 2023-08-01 | ||
| 2022-03-31 | -$0.61 10-Q · filed 2023-05-02 | |||
| 2021-12-31 | -$1.54 10-K · filed 2024-02-09 | |||
| 2021-09-30 | -$0.38 10-Q · filed 2022-11-01 | -$0.86 derived: net income ÷ weighted average shares · filed 2022-11-01 | -$1.46 10-Q · filed 2022-11-01 | -$1.74 derived: net income ÷ weighted average shares · filed 2023-02-10 |
| 2021-06-30 | -$0.48 10-Q · filed 2022-08-02 | -$1.08 10-Q · filed 2022-08-02 | -$1.36 derived: net income ÷ weighted average shares · filed 2023-02-10 | -$1.74 derived: net income ÷ weighted average shares · filed 2023-02-10 |
| 2021-03-31 | -$0.60 10-Q · filed 2022-05-03 | -$0.88 derived: net income ÷ weighted average shares · filed 2023-02-10 | -$1.26 derived: net income ÷ weighted average shares · filed 2023-02-10 | -$2.13 derived: net income ÷ weighted average shares · filed 2023-02-10 |
| 2020-12-31 | -$0.28 derived: net income ÷ weighted average shares · filed 2023-02-10 | -$0.66 derived: net income ÷ weighted average shares · filed 2023-02-10 | -$1.53 derived: net income ÷ weighted average shares · filed 2023-02-10 | -$2.19 10-K · filed 2023-02-10 |
| 2020-09-30 | -$0.39 10-Q · filed 2021-11-02 | -$1.26 derived: net income ÷ weighted average shares · filed 2021-11-02 | -$1.93 10-Q · filed 2021-11-02 | |
| 2020-06-30 | -$0.88 10-Q · filed 2021-08-03 | -$1.56 10-Q · filed 2021-08-03 | ||
| 2019-12-31 | -$1.40 10-K · filed 2022-02-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |